Handelsbanken Fonder’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Handelsbanken Fonder’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17,000	Closed	-$909K	–	257
2016 Q1	$909K	Sell	17,000 -44,500	-72%	-$3.28M	0.04%	131
2015 Q4	$6.95M	Buy	+61,500	New	+$6.78M	0.13%	148

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Handelsbanken Fonder's ANAC Position: Q2 2016 in Review

Handelsbanken Fonder sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 17,000 shares — an estimated $909K sold.

Handelsbanken Fonder first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $6.95M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Handelsbanken Fonder reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Handelsbanken Fonder sold 17,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $909K.
Handelsbanken Fonder first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
Handelsbanken Fonder's ANACOR PHARMACEUTICALS INC COM position peaked at $6.95M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Handelsbanken Fonder's 13F filing for Q2 2016, filed 15 Jul 2016.